Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2008-07-22
2011-11-08
Mertz, Prema (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S004000
Reexamination Certificate
active
08053199
ABSTRACT:
The present invention discloses a method for classifying individuals into those who have airway hyperreactvitiy and those with asthma based on cytokine expression patterns. It is contemplated that such a method will enable rapid identification of individuals requiring intensive treatment for asthma, thereby reducing morbidity and improving quality of life for those affected.
REFERENCES:
Bullens et al (2006), Respiratory Research, 7:135.
Bhattacharjee, et al. Classification of Human Lung Carcinomas by mRNA Expression Profiling Reveals Distinct:Proc National Academy Science, Nov. 20, 2001, vol. 98, No. 24, pp. 13790-13795.
Deykin A. et al. Biomarker-driven Care in Asthma: Are we there?Journal of Allergy and Clinical Immunology, Sep. 2006, vol. 118, No. 3, pp,. 565-568.
Golub, T.R. et al. Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring:Science, Oct. 15, 1999, vol. 286, No. 5439, pp. 531-537.
Godard P., et al. Costs of Asthma are Correlated with Severity a 1-yr Prospective Study:European Respiratory Journal, 2002, vol. 19, pp. 61-67.
Holgate, S.T. et al. Release of RANTES, MIP-1 ∞, and MCP-1 into Asthmatic Airways Following Endobronchial Allergen Challenge:American Journal of Respiratory and Critical Care Medicine, 1997, vol. 156, pp. 1377-1383.
Jatakanon, A. et al. Neutrophilic Inflammation in Sever Persistent Asthma;American Journal of Respiratory and Critical Care Medicine, 1999, vol. 160, No. 1532-1539.
Kapp, A.V. et al. Discovery and Validation of Breast Cancer Subtypes;BioMed Central Genomics, 2006, vol. 7, No. 1, p. 231.
Moore et al. Characterization of the Sever Asthma Phenotype by the National Heart, Lung, and Bloog Institute's Severe Asthma Research Program;Journal of Allergy and Clinical Immunology, 2007, vol. 119, No. 2, pp. 405-413.
Moore, et al. Sever Asthma: An overview;Journal of Allergy and Clinical Immunology, Mar. 2006, vol. 117, pp. 487-494.
Quinlan, et al. C4.5: Programs for Machine Learning:Machine Learning, 1994, vol. 16, pp. 235-240.
Serra-Battles, et al. Costs of Asthma According to the Degree of Severity:European Respiratory Journal, 1998, vol. 12, pp. 1322-1326.
Tomas, MS et al. Regulation of Cockroach Antigen-Induced Allergic Airway Hyperreactivity by the CXCR3 Ligand CXCL91:The Journal of Immunology, 2004, vol. 173, pp. 615-623.
Wenzel, SE et al. Evidence that Severe Asthma Can be Divided Pathologically into two Inflammatory Subtypes with Distinct Physiologic and Clinical Characteristics;America Journal of Respiratory and Critical Care Medicine, 1999, vol. 160, No. 3, pp. 1001-1008.
Wenzel, et al. Severe asthma: Lessons from the Severe Asthma Research Program:Journal of Allergy and Clinical Immunology, 2007, vol. 119, No. 1, pp. 14-21.
Boetticher Gary D.
Brasier Allan R.
Calhoun William J.
Adler Benjamin Aaron
Mertz Prema
LandOfFree
Molecular phenotyping of severe asthma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Molecular phenotyping of severe asthma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Molecular phenotyping of severe asthma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4288529